Published in

Nature Research, Nature Communications, 1(11), 2020

DOI: 10.1038/s41467-020-18151-y

Links

Tools

Export citation

Search in Google Scholar

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Journal article published in 2020 by Christian von Mering, Zemin Zhang, Yan Zhang, Xuanping Zhang, K. Ye, Z. Zhang, Y. Zhang, Takafumi N. Yamaguchi, Kai Ye, J. Zhang, T. N. Yamaguchi, T. Yugawa, Venkata D. Yellapantula, Christina K. Yung, Christopher J. Yoon and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractThe Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts.